Hepatorenal Syndrome: A Mini Review
Journal Title: Journal of European Internal Medicine Professionals (JEIMP) - Year 2023, Vol 1, Issue 2
Abstract
Hepatorenal syndrome (HRS) is diagnosed in individuals who have no etiologic factors for the development of renal disease other than chronic decompensated liver disease (DLD). HRS represents the end stage of a series of reductions in renal blood flow caused by progressive severe liver injury. HRS is a strong indicator of morbidity and mortality in these patients. A specific treatment approach for HRS is not available because the mechanisms underlying the development of renal dysfunction are not clear. Because of the severe circulatory abnormality and portal hypertension in the background of the clinical aspect, HRS is the most life-threatening entity in DLD patients with acute renal dysfunction.
Authors and Affiliations
Atilla Bulur
Successfully Completed Twin Pregnancy of a Peritoneal Dialysis Patient
This is a letter to the editors. An abstract is not available.
Diagnosis and Treatment of Monogenic Hypertension in Children
Hypertension (HT) is a common public health problem that develops due to primary and secondary causes. The prevalence of HT in children and adolescents is 3.6%. In childhood HT, complex and polygenic factors such as gene...
Dyslipidemia and Kidney: An Updated View
Dyslipidemia is a common concern in various kidney-related conditions, including chronic kidney disease, nephrotic syndrome, kidney transplant patients, and those undergoing dialysis. Dyslipidemia is a significant risk f...
A Rare Case of Multiple and Ectopic Parathyroid Adenoma
This is a letter to the editors. An abstract is not available
The Frequency of ANA-positivity and Inflammatory Markers in COVID-19
Background: Immune system activation plays an important role in pathogenesis and mortality in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The inflammatory response during the disease is caused...